According to the report, the increasing prevalence of drug allergies, particularly to penicillin and morphine, has fueled the demand for allergy diagnostics worldwide.

The report also finds that increasing air pollution and lack of awareness of food and drug allergies in emerging and poor countries are encouraging market players to develop low-cost allergy diagnostic kits.

According to a report published by the World Health Organization, asthma affects around 262 million people worldwide, of whom 461,000 die from asthma.

request sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

The increasing demand for effective treatment and treatment of the root causes of asthma will support the overall expansion of the allergy diagnostics market.

The allergy diagnostics market has experienced sluggish growth during the COVID-19 pandemic. This is because the pandemic led to the suspension of immunological care and distracted healthcare professionals from treating COVID patients.

Virtual care and limited visiting methods have been used for patients with severe asthma or other allergic reactions to limit human contact and stop virus transmission.

The introduction of cost-effective home food sensitivity and allergy diagnostics will spur market growth in the years to come. Such applications will ease the burden on the hospital and laboratories, resulting in a reduction in allergy diagnosis and medical costs.

Significant market growth is expected for the future, as the majority of diagnostic laboratories and hospitals are moving towards automated allergy diagnostics due to their high effectiveness. Canada and the US are likely to offer highly opportunistic prospects and contribute to the overall expansion of the market.

“The increase in cases of food allergies along with the increasing incidence of childhood asthma will catapult the demand for allergy diagnostics during the forecast periodsays the FMI analyst.

competitive landscape

Allergy…